| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |